T.PLI - Triple - Ascending triangleThe ascending triangle keeps repeating.
PLI is in good hands with Abraxis, Celgene, and a dozen more big players.
Biotech seasonality is here for the next months and PLi is in much better shape with the debt waved, and further revenue being forcasted.
Bring on the Japan deal with upfront cash and watch the sp flagpole to $1.00